Skip to main content

Table 3 Adverse Events By Person (AE's)

From: Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: A randomized placebo-controlled pilot study

 

Placebo N(%)

Chamomile N(%)

P-valuea

Any AE

10 (58.8)

6 (35.5)

0.03

   Infections

3 (17.6)

2 (11.8)

1.00

   Headaches

1 (5.9)

1 (5.9)

0.76

   Dizziness

1 (5.9)

0 (0.0)

1.00

   GI Symptoms

4 (23.5)

2 (11.8)

0.66

   Musculoskeletal

2 (11.8)

1 (5.9)

0.76

  1. aBased on Fisher's Exact Test
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us